Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
Also in the Knowledge Center
/ Oct 19, 2026
A dimensionless framework for hold-up mass prediction and scale transfer in continuous linear blending
Read more
Scientific Article
/ Oct 26, 2026
Streamlined development of continuous blending through integrated process understanding and predictive modeling
Read more
Scientific Article
/ Aug 04, 2026
Hovione: Accelerating Oral Drug Development Through Rapid Prototyping and Integrated Development Strategies
Read more
Scientific Article